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Research Highlights 
• Telemonitoring interventions should to be adjusted to their target population; 
• Assessment of patients’ acceptance of telemonitoring technology should be 
considered prior to its implementation; 
• Future research should consider the inclusion of easy-to-use technology and more 
training sessions; 
• Frequency of data collection/transmission should be flexible to improve adherence; 
• Changes in patients’ self-management behavior should be explored in future studies. 
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Summary Points 
What is already known on the topic: 
• The number of patients with COPD being managed at home is increasing to reduce 
health-related costs while trying to increase patients’ comfort; 
• Home telemonitoring is an innovative approach which facilitates patients’ 
management at home, by exchanging information between patients and their 
healthcare professionals; 
• There are systematic reviews available on the topic of home telemonitoring in 
respiratory patients and, specifically, in patients with COPD. However, they lack 
information about telemonitoring methodologies and patients’ adherence. 
What has this study added to our knowledge: 
• Home telemonitoring interventions, although promising, still need to be adjusted 
to ensure their suitability to the target population. Assessment of patients’ needs, 
characteristics and acceptance of the technology may facilitate patients’ 
adherence to telemonitoring regimens; 
• Future home telemonitoring interventions for COPD should consider the 
inclusion of easy-to-use technology and more training sessions to facilitate 
patients’ education on the use of the technologies, and they should be flexible in 
frequency of data collection and transmission to improve adherence; 
• The impact of telemonitoring interventions on patients’ self-management 
behavior and satisfaction should also be explored, as well as their associations 
with patient outcomes and healthcare utilization. 
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ABSTRACT 
Aim: This systematic review aimed to provide a comprehensive description of the 
methodologies used in home telemonitoring interventions for Chronic Obstructive Pulmonary 
Disease (COPD) and to explore patients’ adherence and satisfaction with the use of 
telemonitoring systems.  
Methods: A literature search was performed from June to August and updated until December 
of 2012 on Medline, Embase, Web of Science and B-on databases using the following 
keywords: [tele(-)monitoring, tele(-)health, tele(-)homecare, tele(-)care, tele-home health or 
home monitoring] and [Chronic Obstructive Pulmonary Disease or COPD]. References of all 
articles were also reviewed. 
Results: Seventeen articles were included, 12 of them published from 2010 to the present. The 
methodologies were similar in the training provided to patients and in the data collection and 
transmission processes. However, differences in the type of technology used, telemonitoring 
duration and provision of prompts/feedback, were found. Patients were generally satisfied and 
found the systems useful to help them manage their disease and improve healthcare 
provision. Nevertheless, they reported some difficulties in their use, which in some studies 
were related to lower compliance rates.  
Conclusions: Telemonitoring interventions are a relatively new field in COPD research. Findings 
suggest that these interventions, although promising, present some usability problems that 
need to be considered in future research. These adjustments are essential before the 
widespreading of telemonitoring. 
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INTRODUCTION 
Chronic Obstructive Pulmonary Disease (COPD) is a highly prevalent disease worldwide [1]. As 
the disease progresses, patients become more susceptible to respiratory exacerbations which 
cause frequent hospital admissions and readmissions and, thus, have a considerable impact on 
patients’ quality of life and healthcare costs [2, 3]. This poses COPD as a public health problem 
of increasing concern to healthcare systems worldwide [4]. A number of interventions have 
been developed to help patients self-manage their disease and improve their quality of life, 
therefore reducing pressures on healthcare resources. Recent studies have shown that the 
number of patients with COPD being managed at home is increasing to reduce health-related 
costs while trying to increase patients’ comfort [5]. 
Home telemonitoring is a relatively new approach (dating back to the early 1990s) which 
facilitates patients’ management at home [6]. It is defined as the use of telecommunication 
technologies to transmit data on patients’ health status (e.g., oxygen saturation, vital signs) 
from home to a healthcare center [6, 7]. By systematically monitoring patients’ health 
condition, home telemonitoring can be used for a timely assessment of an acute exacerbation 
or as a mechanism to generate alarms to the patients and/or healthcare professionals when 
clinical changes that may constitute a risk to the patient occur [8]. This approach aims to 
empower patients to manage their disease (e.g., by recognizing the early signs of 
exacerbations), improve patient-professional interactions and prevent unplanned hospital 
admissions [8, 9]. 
Five systematic reviews are available on the topic of home telemonitoring in respiratory 
patients [7] and, specifically, in patients with COPD [5, 10-12]. However, they focus on clinical 
outcomes (e.g., quality of life) [7, 11, 12], reduction in healthcare service utilization [5, 7, 11, 
12], feasibility and use [7], and on economic [5, 7] and organizational [10] impacts of 
telemonitoring. None of these studies provides a comprehensive description of the 
6 
 
telemonitoring methodologies, which is essential to enhance the design of future 
telemonitoring interventions and facilitate comparisons between studies. Furthermore, 
optimal interventions require patients’ adherence [13], but there is still limited information 
about adherence to telemonitoring in COPD research. Previous studies on telemonitoring in 
different health conditions have suggested that adherence is related to patients’ satisfaction 
with the telemonitoring regimens [14-16], so satisfaction should be considered when assessing 
patients’ adherence. Thus, this systematic review aimed to: (1) provide a comprehensive 
description of the methodologies used in home telemonitoring for COPD and; (2) describe the 
current state of literature on patients’ adherence and satisfaction with the use of 
telemonitoring systems. 
 
METHODS 
Information sources and search strategy 
A literature search was performed from June to August of 2012 in the medical databases 
Medline (1948-2012) and Embase (1974-2012) and wide-ranging scientific databases Web of 
Science (1970-2012) and B-on Online Knowledge Library (1999-2012). These databases were 
included to ensure that all relevant articles were retained. Search terms were based on a 
combination of the following keywords: [tele(-)monitoring or tele(-)health or tele(-)homecare 
or tele(-)care or tele-home health or home monitoring] and [Chronic Obstructive Pulmonary 
Disease or COPD]. Search was customized for each database according to their filtering 
specificities. Additional searches for relevant studies were performed within the bibliography 
of the selected articles and weekly automatic updates retrieved from the databases until 
December of 2012. 
 
Eligibility criteria and study selection 
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This systematic review is structured according to Preferred Reporting Items for Systematic 
Reviews and Meta-Analyzes (PRISMA) guidelines [17, 18]. Eligible studies included adult people 
with a diagnosis of COPD whose health condition was telemonitored at home. Home 
telemonitoring was defined according to the following criteria [6, 7]: i) patients or their 
caregivers had to periodically record patients’ clinical data (e.g., physiological signs or 
symptoms) at home; ii) these data had to be transmitted using telecommunication 
technologies from patients’ home to a monitoring center. Studies were excluded if they: i) 
included patients with diseases other than COPD (i.e., the intervention was not specific to 
COPD population); ii) included only regular telephone calls, video-consultation or 
teleconference interventions without telemonitoring clinical data; iii) involved downloading 
the data during healthcare visits or at the end of the study; iv) were limited to a technical 
description of the technology employed; vi) provided telemonitoring in other places than 
patients’ home. Studies without information on patients’ adherence and satisfaction were still 
retained in the review to enable a full description of the methodologies used in home 
telemonitoring (the first aim of the paper). In this review, the term adherence followed the 
definition proposed by the World Health Organization (2003) [13] and consisted of the extent 
to which the patient's behavior corresponds to the recommendations provided by the 
monitoring center regarding the use of the telemonitoring technology. The studies considered 
for review were randomized controlled trials (RCTs) and quasi-experimental studies; 
observational studies which did not include a telemonitoring intervention and case studies 
were excluded. Non-original articles (e.g., review papers, editorials, commentaries to articles, 
study protocols) and abstracts of communications or meetings were not considered suitable 
and, therefore, were excluded from this review although their reference list was reviewed 
closely. Papers without abstracts or written in languages other than English, Portuguese and 
Spanish were also excluded.  
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Study selection followed the stages recommended by the guidelines for conducting systematic 
reviews [19]. Initial screening of articles was based on type of publication and relevance for the 
scope of the review according to their title, abstract and keywords. Then, the full-text of 
potentially relevant articles was screened for content to decide its inclusion in the review. 
Studies with multiple publications were identified to avoid duplicate reports.  
 
Data collection process 
One reviewer extracted the data from the included studies and a second reviewer checked the 
extracted data. Disagreements were resolved by discussion between the two reviewers. Data 
were extracted in a structured table-format (developed prior to data collection) according to 
the following topics: first author’s last name and year of publication, study design, country 
where the study was conducted, participants, type(s) of intervention(s), telemonitoring 
methodology, patients’ adherence and satisfaction. The telemonitoring methodology data 
were synthesized in sub-categories: i) telemonitoring duration; ii) type of technology; iii) 
patients’ training to use the system; iv) data collection and transmission; v) use of prompts, 
reminders and/or feedback and detection of health deterioration. Patients’ adherence was 
obtained by accessing dropout and compliance rates of patients who participated in the 
telemonitoring interventions. When available, reasons for non-adherence were also collected. 
Meta-analyzes could not be performed due to the nature of the data collected (description of 
methodologies) and lack of comparable outcomes to measure patients’ adherence and 
satisfaction. Instead, a narrative synthesis was employed to synthesize the findings [20]. 
 
Quality assessment 
Quality of studies was formally assessed according to the guidelines for conducting systematic 
reviews [19], using a modified version of the scoring system developed by Hailey et al. [21] to 
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evaluate telemedicine research. This modified version was summarized in a recent systematic 
review on COPD [12] and consists of 5 levels, from grade A (high quality) to E (poor quality), 
taking into consideration the study design and performance. For study design, scores were 
assigned to 4 types of study: large RCTs (≥50 subjects in each arm), small RCTs, prospective 
non-randomized studies and retrospective studies. For study performance, five areas of 
interest were considered: patient selection, description/specification of the intervention, 
specification and analysis of study, patient disposal and outcomes reported.  
The quality of studies was independently assessed by two reviewers and inter-rater agreement 
calculated using the Cohen’s kappa coefficient. The kappa values can be interpreted as [22]: 
slight agreement (≤0.20), fair agreement (0.21–0.40), moderate agreement (0.41–0.60), 
substantial agreement (0.61–0.80) and almost perfect agreement (≥0.81). Disagreements 
between reviewers were resolved by consensus. 
 
RESULTS 
Study selection 
The database search identified 455 records. After duplicates removal, 130 records were 
screened for relevant content. During title, abstract and keyword screening, 109 articles were 
excluded due to the following reasons: non-original articles (n=55), case studies (n=3), no 
abstract provided (n=6), inclusion of non-COPD patients (n=17), absence of telemonitoring 
interventions (n=22) and other languages rather than English, Portuguese or Spanish (n=6). 
The full-text of the 21 potentially relevant articles was assessed and 8 articles were excluded. 
Reasons for exclusion included: no telemonitoring information (n=4), laboratory testing of the 
system (n=2), participants with diseases other than COPD (n=1) and provision of 
teleconsultations alone (n=1). Automatic updates from the databases and search for relevant 
articles within the bibliography of selected articles retrieved 4 articles, which were also 
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included (Figure 1). From the articles included in the analysis, eight were identified as referring 
to the same studies: 2 articles per study in 2 studies [23-26] and 4 articles pertaining to a single 
study [27-30]. In total, 17 articles on 12 studies were included, all published in English. 
(Insert Figure 1 about here) 
 
Study characteristics 
Study characteristics are presented in Table 1. Most studies were randomized controlled trials 
(n=5), followed by uncontrolled before-and-after studies (n=4) and non-randomized controlled 
trials (n=3). Sample sizes varied from 20 to 165 patients with COPD, mostly older people. Ten 
studies included specifically patients in advanced stages of the disease. Most studies recruited 
patients during/following hospital admission or those receiving specialized care at the hospital 
or at home. 
In 6 studies, the intervention consisted of telemonitoring clinical data plus other health care 
components such as: in-home nurse visits (n=1), virtual visits/consultations or regular 
telephone calls from the healthcare team (n=5) or provision of education (n=5). 
(Insert Table 1 about here) 
 
Quality assessment 
Quality levels differed across articles: 4 were rated A (high quality) [26-28, 31], 7 were rated B 
(good quality) [25, 32-37], 5 were rated C (fair to good quality) [23, 24, 29, 30, 38] and 1 was 
rated E (poor quality) [39]. The articles rated as A and 3 articles rated as B [25, 32, 33] were 
referring to randomized controlled trials. Cohen’s kappa coefficient revealed substantial 
agreement between raters (Ƙ=0.78, p=0.001) for study quality levels. 
 
Description of telemonitoring methodology 
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Telemonitoring duration  
The length of the telemonitoring period ranged from 2 to 12 months (Table 1). While 8 studies 
defined a specific period for telemonitoring, 2 reported that the duration was defined 
according to patients’ needs. 
 
Technology 
The telemonitoring systems were different across studies (Table 1). Some studies provided 
detailed information about them, including the peripheral devices that could be connected to 
a main device, such as: oximeters (n=5), spirometers (n=3), blood pressure monitors (n=1), 
thermometers (n=1), electrocardiographs (n=1), respiratory rate sensors (n=1) and/or 
electronic stethoscopes (n=1). The main device was frequently a mobile/web phone with an 
integrated touch-screen (n=4) or a touch-screen computer (n=1) that allowed patients to 
record data collected via the peripheral devices and/or to answer questions about their 
symptoms and disease management. Two studies used the same main device, which also 
provided patients with information about the disease and/or educational questions to answer 
regularly. 
 
Patients’ training 
Training to use the telemonitoring systems was described in 9 studies (Table 2). Four studies 
reported that patients were trained in their homes during the initial home visit by a nurse 
working in the telemonitoring project. Patients had to demonstrate the use of the system in 3 
studies and they received information about the normal clinical parameters in only 1 study. In 
2 studies, ongoing support could be given according to patients’ needs. 
(Insert Table 2 about here) 
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Data collection and transmission 
Table 3 summarizes the clinical data collected through the telemonitoring systems. The most 
common parameters collected were symptoms (n=9), oxygen saturation (n=8), spirometric 
parameters (n=6), medication (n=6), heart rate (n=5), temperature (n=3) and weight (n=3). 
(Insert Table 3 about here) 
Data collection process was similar across studies. Answers to symptoms and self-management 
questions (e.g., changes in medication, patient knowledge about COPD) were performed 
manually using touch-screen monitors. Regarding clinical data, it was not always clear if the 
information had to be inserted manually or if the process was automatic (i.e., the peripheral 
devices enabled automatic data transfer to the main device). Four studies required data 
collection at a specific time of the day and in 2 studies the data were collected more than once 
per day (Table 3). 
Data were transmitted on a daily basis in almost all studies. This process was usually 
performed via telephone line to a secure server, either on real time (n=2) or at a specific time 
of the day (n=2). Data were received in a healthcare center, call center or manufacturer center. 
There, healthcare professionals could monitor the data, generally on a daily basis (Table 2). In 
6 studies, the information transmitted was automatically analyzed and alerts were sent to 
healthcare professionals and/or researchers when readings fell outside pre-established 
parameters. When data were not transmitted on consecutive days, patients were contacted 
via telephone call (n=3) or via message in the monitor screen (n=1). 
 
Reminders, feedback and detection of health deterioration 
Three studies provided reminders or prompts via the telemonitoring system to patients (Table 
2). Prompts consisted of step-by-step instructions to help patients complete the 
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measurements and/or questions or instructions to attach a peripheral to the main device. One 
study provided patients with a medication and pursed-lip breathing reminder. 
Two types of automatic feedback could be given by the systems: feedback about blank and/or 
correct/incorrect answers (n=1) or alerts when readings fell outside pre-established 
parameters (n=3). When deterioration of health condition was detected, patients could 
contact the healthcare professionals (n=1) or be contacted via telephone calls (n=9). Patients’ 
answers about their health condition could determine the next action to be taken (Table 2): 
contact of a physician to make a decision about treatment (n=4) or providing patients with an 
action plan and an emergency supply of medication to commence as soon as an exacerbation 
was recognized (n=2). 
 
Patients’ adherence and satisfaction 
Compliance and dropout rates 
Since these data were intended to inform about the adherence of patients to telemonitoring 
regimens, information about the control groups (if it existed) was not included. 
All studies provided information on patient dropouts. From these, only 3 provided information 
on dropouts before intervention [23, 25, 31]. Reasons for withdrawal included [31]: worsening 
of patient’s physical condition, financial-related reasons (patients did not have enough money 
to attend the follow-up and to afford the additional cost of recharging the batteries of the 
device every other day), refusal to use the belt for measuring respiratory rate in cold weather, 
the device was too difficult to carry around at work or the frequency of telemonitoring was too 
demanding (i.e., 3 times/day on weekdays). 
Five of the studies which provided dropout information during the intervention period had a 
high number of dropouts (≥20%) and/or low compliance rates (≤80%) [23, 31, 32, 36, 37], 
while 5 reported low dropout rates [27, 33-35, 38]. The frequency of data transmission was 
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related to lower compliance rates in one study. Chau et al. [31] found that patients’ 
compliance rates were high when data were transmitted once per day (98% for oxygen 
saturation and 83% for respiratory rate), but they decreased when the frequency was the 
recommended 3 times a day (79% and 60%, respectively).  
Overall, dropout reasons were related to usability problems (n=2) [23, 37] and technical 
problems with the system or the telephone line (n=3) [33, 35, 37]. Other reasons not related to 
the telemonitoring system itself included the occurrence of respiratory exacerbations or illness 
(n=3) [23, 27, 31], relocation (n=2) [32, 36] and patients’ death (n=4) [25, 32, 36, 38]. 
 
Patients’ satisfaction 
Nine studies assessed patient satisfaction with the telemonitoring system (Table 4). Studies 
used quantitative scales/questionnaires (n=5), qualitative interviews (n=1) or both (n=2). Only 
one study did not provide information about how these data were collected. Patient 
satisfaction assessments were conducted face-to-face or through telephone calls. Most 
quantitative data were collected using non-validated scales and none of the studies used the 
same questionnaire. Thus, a meta-analysis could not be performed.  
(Insert Table 4 about here) 
Overall, patients found the technology easy to learn and/or use (n=7) and useful (n=5). Most 
patients reported that the system improved self-management of their health condition, as 
they: had a better understanding of their disease, symptoms and ways to control them; were 
more involved in their health care; and recognized earlier the signs of exacerbations. In the 
patients’ perspective, the system also improved the care received from healthcare 
professionals. Patients felt a sense of security and reassurance when using the system because 
they knew their health condition was being monitored and they would be contacted if 
deterioration occurred (n=5). Furthermore, patients reported that the system helped them to 
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improve communication with healthcare professionals and facilitated the access to 
professional advice (n=3). Levels of satisfaction were reduced regarding the medication 
prompt (n=2); patients did not find it useful because they already took their medication 
correctly. 
In some studies, open-ended questions provided additional information about the difficulties 
felt by patients when using the systems (n=3). Patients reported the following difficulties 
regarding the device itself: the display screen was too small and words too small to read; the 
touch-screen was difficult to use due to deficits in sensation and poor fine motor control; push 
buttons were too small to manipulate and the button to initiate an emergency call too 
sensitive or the volume was difficult to adjust. In one study, patients mentioned that the 
mobile phone was far too technologically advanced for them and they did not know how to 
operate when unexpected characters were displayed. As a result, some patients needed help 
from their caregiver to transmit the data. Difficulties such as determining the precise area to 
apply the device or using the belt of the respiratory rate sensor due to dyspnea or discomfort 
were also described in 2 studies. 
Some concerns with the system functioning were reported: the batteries of peripheral devices 
were of short-lived duration and needed a long time to charge, power supply connection was 
small and confusing (n=1) and the background noise of the computer fan caused some 
problems in smaller living situations (n=1). Other concerns included the uncertainty of data 
transmission (n=3) and the limited portability of the device (n=1). Suggestions to improve the 
system were given in two studies and consisted of adding a blood pressure monitor, ensuring 
the transmission of clinical data and giving real time feedback. 
 
DISCUSSION 
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This systematic literature review provided a comprehensive description of the methodologies 
of home telemonitoring interventions in COPD and summarized the findings related to 
patients’ adherence and satisfaction with the use of telemonitoring systems. The majority of 
the articles were published from 2010 to the present, suggesting that telemonitoring 
interventions are a relatively new field in COPD research. Protocols of the telemonitoring 
studies were similar in several aspects such as the training provided to patients and the 
process of data collection and transmission. Studies diverged on the type of technology used, 
telemonitoring duration, and on the provision of prompts, reminders and/or feedback. 
Training was usually provided in the initial home visit. However, this training may not have 
been enough to allow easy use of the systems, as many difficulties were encountered. 
With respect to data collection, most studies lacked information about whether data had to be 
inserted manually or if the process was automatic, hindering study replication. Furthermore, 
some of these studies required data collection/transmission at a specific time of the day or 
more than once a day. These options were related to lower compliance rates in one study [31]. 
The results suggest that the moment and frequency of data collection/transmission should be 
flexible to meet patients’ preferences and specific needs. However, the optimal frequency of 
data collection/transmission has not yet been defined in the literature. 
Information on the type of technology used was lacking in some studies. Generally, a main 
device was connected to one or more peripheral devices. Most studies did not provide systems 
with options for adjusting them to each patient, making the use of those systems difficult. 
Some patients identified difficulties in manipulating the devices and in viewing the information 
provided on screen [31]. According to the review by Botsis and Hartvigsen [40], telemonitoring 
systems should fulfill the following criteria: i) be easy to use; ii) operate without interruptions; 
and iii) provide security and confidentiality of data collected. These criteria were not fully 
addressed in the included studies, since patients were not always comfortable about using the 
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technology to monitor their health condition. Furthermore, the difficulties felt by patients may 
have been a contributor to the high dropouts found in some studies, as suggested by Sanders 
and co-workers in their study exploring the factors related to the non-adherence to 
telemonitoring interventions [16]. To overcome these difficulties, it has been suggested that 
patients should receive training over a period of several days to help them learn to use the 
new technology and, therefore, optimize its use [41]. As the success of a telemonitoring 
system depends on how well it serves the needs of the target population [41], assessment of 
patients’ acceptance of the system may also be useful to avoid dropouts and ensure patients’ 
compliance. According to the American Telemedicine Association [42], evaluating and tailoring 
technology systems to specific user populations may contribute significantly to reduce 
technophobia among potential users. 
Despite the usability problems, most patients reported that the system provided them with a 
better understanding of their disease and helped them to recognize the earlier signs of an 
exacerbation. These findings support the belief that telemonitoring may improve self-
management of the disease [43]. According to Bourbeau et al. [44], self-management refers to 
the various tasks that a person carries out for management of their condition, in order to 
control their disease and improve their well-being. By helping patients to be aware of their 
symptoms and act in case of exacerbations, home telemonitoring may have facilitated 
patients’ self-management. Furthermore, patients felt secure and reassured when using the 
system, because they knew that they would be contacted if deterioration occurred. The 
worsening of symptoms associated with COPD exacerbations is usually present for days before 
hospital admissions [24]. Thus, home telemonitoring may be a valuable tool to detect these 
changes sooner and allow an earlier intervention to reduce the severity of exacerbations. This 
is particularly important since exacerbations contribute to the deterioration of patients’ clinical 
status [3]. 
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The results of this review showed that patients were overall satisfied with the telemonitoring 
systems. This is an encouraging finding, since one of the aims of home telemonitoring is to 
explore the potential of the monitoring services to provide a continuum of care and, therefore, 
patients’ satisfaction must be high for successful innovations to achieve a significant change in 
practice patterns. However, this positive impact may be questionable and even overestimated, 
since the included studies used poorly constructed instruments. According to previous 
literature [5], the concept of patient satisfaction is still not well defined and validated 
instruments are lacking.  
  
Limitations 
The present study has several limitations that need to be acknowledged. First, the study was 
restricted to English, Portuguese and Spanish languages. Although six records written in other 
languages were excluded, they could be relevant for the scope of the review. Second, this 
review included studies which were not specific for patients with COPD but had a sub-group of 
patients with this disease, and/or studies with different interventions (telemonitoring alone 
versus telemonitoring plus other health care components). This may have contributed to the 
differences found between studies. Nevertheless, this was deemed necessary to gather all 
information about the methodologies used in home telemonitoring for COPD. Finally, patients’ 
satisfaction was explored regardless of clinical outcomes and healthcare utilization. Thus, it 
was not possible to assume that more satisfied patients were those with improved outcomes 
and reduced healthcare utilization.  
 
Recommendations for future telemonitoring interventions 
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This review points out important methodological aspects that should be considered by 
researchers and healthcare professionals when developing home telemonitoring interventions 
for patients with COPD, and it provides recommendations for future interventions: 
- The inclusion of more training sessions may facilitate patients’ education on the use of the 
systems;  
- Assessment of patients’ needs, characteristics and acceptance of the telemonitoring 
technology should be considered prior to its implementation, as it may help adjusting the 
intervention to the target population; 
- Studies should consider the inclusion of easy-to-use technology for patients with COPD, 
including those with disabilities;  
- The frequency of data collection and transmission should be flexible to improve adherence to 
telemonitoring interventions. As the optimal frequency of data collection/transmission has not 
been set yet, future research should also explore this topic; 
- The potential of telemonitoring interventions to change patients’ self-management behavior, 
as well as its associations with patient outcomes and healthcare utilization, should be explored 
to improve the evidence on this topic; 
- Patients’ satisfaction with the use of systems should be further explored using more robust 
and validated instruments. Alternatively, a thorough qualitative analysis can be conducted to 
enable an in-depth understanding of patients’ satisfaction and the use of that information to 
improve future technology designs. 
 
CONCLUSION 
Home telemonitoring interventions are a relatively new field in COPD research. Findings 
suggest that these interventions, although promising, still need to be adjusted to ensure their 
suitability to the target population. This study provides important recommendations for future 
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telemonitoring interventions, such as the inclusion of additional training sessions to facilitate 
patients’ education on the use of the systems and the assessment of patients’ characteristics 
and acceptance of the technology prior to its implementation. These adjustments are essential 
before the widespreading of telemonitoring can occur. Future research should also investigate 
the impact of these interventions on patients’ self-management behavior and satisfaction, and 
explore their associations with patient outcomes and healthcare utilization. 
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Table 1 - Main characteristics and description of the technology used in the studies. 
First author 
(year) 
Study 
design 
Country Participants Type(s) of intervention(s) or 
comparator(s) 
Telemonitoring 
duration 
Description of technology 
Antoniades 
(2012)[32] 
RCT Australia 44 patients with moderate to 
severe COPD and with ≥1 hospital 
admissions/year randomized in 2 
groups: IG (n=22) and CG (n=22). 
IG: home telemonitoring; 
CG: usual care. 
12 months Laptop computer with peripherals: 
blood pressure cuff and 
stethoscope, pulse oximeter, 
pneumotachograph, 
electrocardiogram touch plate and 
thermometer.  
Chau (2012)[31] RCT Hong Kong 53 older people with moderate to 
very severe COPD randomized in 2 
groups: IG (n=30) and CG (n=23). 
IG: home telemonitoring plus in-
home nurse visits with provision of 
education. 
CG: in-home nurse visits with 
provision of education. 
2 months 
(mean duration 
54.36 days) 
Mobile phone with a touch-screen 
monitor and peripheral devices: 
oximeter and respiratory rate 
sensor.  
Dale (2003)[39] UBA United 
Kingdom 
55 patients with COPD. Home telemonitoring plus 
additional telephone questions. 
3 months Oximeter and home weight scale. 
Dinesen RCT Denmark 111 patients with severe or very IG: home telemonitoring plus in- 4 months Telemonitor device. Other devices 
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(2012)[27], 
Haesum 
(2012)[28], 
Jensen 
(2012a)[29], 
Jensen 
(2012b)[30] 
severe COPD randomized in 2 
groups: IG (n=60) and CG (n=51). 
home exercises plus a monthly 
video meeting. 
CG: in-home exercises. 
(not connected to the main 
device): weight scale, blood 
pressure monitor, oximeter, 
spirometer and step counter (in 
Dinesen (2012) and Haesum 
(2012)). 
Kim (2012a) 
[23], (2012b) 
[24] 
Non-
equivalent 
multiple-
group UBA 
Korea 144 patients with COPD randomly 
allocated in 3 groups: IG1 (n=78), 
IG2 (n=36) and IG3 (n=30). 
IG1: home telemonitoring; 
IG2: home telemonitoring plus 
education plus mobile phone 
service; 
IG3: home telemonitoring plus 
education plus video phone 
teleconsultation. 
6 months Integrated platform with 
peripherals: spirometer, oximeter 
and electronic stethoscope. 
Koff (2009)[33] RCT United 
States of 
America 
40 patients with COPD grades 3 
and 4 according to the Global 
Initiative for Chronic Obstructive 
IG: home telemonitoring plus 
education plus usual care. 
CG: usual care. 
3 months Health Buddy® device. Other 
devices (not connected to the main 
device): oximeter, pedometer and 
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Lung Disease criteria [3]. mini-spirometer. 
Lewis 
(2010a)[25], 
(2010b)[26] 
RCT United 
Kingdom 
40 patients with moderate to 
severe COPD randomized in 2 
groups after undertaken 
pulmonary rehabilitation: IG (n=20) 
and CG (n=20). 
IG: home telemonitoring during 26 
weeks and usual care in the 
following 26 weeks. 
CG: usual care for 52 weeks. 
6 months Hand-held telemonitor (Docobo® 
Health HUB) to display questions 
and a peripheral oximeter. A 
manual thermometer was also 
provided. 
Paré (2006)[34] NRCT Canada 30 patients with severe COPD 
assigned in 2 groups: IG (n=20) and 
CG (n=10). 
IG: home telemonitoring; 
CG: usual home care. 
6 months Web phone with a touch-screen 
monitor and a modem. 
Sicotte 
(2011)[38] 
NRCT Canada 46 patients with severe COPD 
assigned in 2 groups: IG (n=23) and 
CG (n=23). 
IG: home telemonitoring; 
CG: usual home care. 
Mean±SD of 
146.7±72.3 
days 
Web phone with a touch-screen 
monitor. 
Sund (2009)[37] UBA United 
Kingdom 
20 patients with moderate to 
severe COPD. 
Home telemonitoring.  6 months Mobile phone with a touch-screen 
and a peripheral spirometer. 2 
software packages to enter data 
about symptoms and spirometry. 
Trappenburg NRCT Netherlands 165 patients with moderate to IG: home telemonitoring plus 6 months Health Buddy® device with 4 large 
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(2008)[36] severe COPD: IG (n=101) and CG 
(n=64). 
education plus usual care; 
CG: usual care. 
buttons to present questions and 
education. 
Ure (2012)[35] UBA  27 patients with moderate to 
severe COPD. 
Home telemonitoring. 2 months Touch-screen computer and 
peripherals: Bluetooth-linked 
oximeter and spirometer. 
UBA - Uncontrolled before-and-after study; NRCT - non-randomized controlled trial; RCT – Randomized controlled trial; NA – no available information; COPD 
– chronic obstructive pulmonary disease; IG – intervention group; CG – control group; SD – standard deviation. 
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Table 2 - Patients’ training and specificities of data transmission and management. 
First author 
(year) 
Training to use the system Reminders, prompts 
and/or feedback 
Data transmission  Data management Detection of health deterioration 
Antoniades 
(2012)[32] 
In the initial home visit. 
Ongoing in-home support 
available, if required.  
On-screen prompts to 
complete the 
measurements and 
questionnaire. 
Via a telephone line to a 
central server. 
A nurse monitored the 
data on weekdays.  
 
Significant changes triggered a 
contact to a physician/nurse or to the 
patient for further assessment. 
Chau (2012)[31] In the initial home visit, 
provided by a nurse, with 
return demonstration.  
Medication and pursed-lips 
breathing reminders with a 
feedback function. 
Via a radio service to an 
online network platform 
on a base station.  
A nurse monitored the 
data. 
Immediate action taken when 
changes in clinical data occurred (not 
specified). 
Dale (2003)[39] In the initial home visit, 
provided by a nurse. 
NA Via a telephone line to a 
clinical response center. 
 
A nurse monitored the 
data on a daily basis.  
Clinical changes could lead to further 
assessment or treatment. A physician 
could be contacted for decision-
making. 
Dinesen 
(2012)[27], 
Haesum 
In the initial home visit, 
with advice on how to 
exercise. 
NA Through a secure line using 
wireless to a healthcare 
center/hospital and stored 
Healthcare professionals 
monitored the data. 
Healthcare professionals could give 
advice (not specified). 
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(2012)[28], 
Jensen 
(2012a)[29], 
Jensen 
(2012b)[30] 
in patient’s database. 
Kim (2012a) [23], 
(2012b) [24] 
At the hospital, with return 
demonstration, and then 
at home. Ongoing in-home 
support available, if 
required. 
NA Via a cable modem or 
digital subscriber lines. 
NA NA 
Koff (2009)[33] In the initial home visit, 
provided by a nurse, with 
education about the 
normal clinical parameters. 
Advice to contact the 
coordinator when 
classified as red flags. 
Via a telephone line to the 
databank, each night.  
The coordinator monitored 
the data in the following 
morning of data 
transmission. 
Patients automatically stratified into 
3 color-coded groups and contacted 
if persistent red/yellow flags 
appeared. A red flag or a patient call 
led to the contact of the primary care 
physician. 
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Lewis 
(2010a)[25], 
(2010b)[26] 
In the initial home visit 
(~1h per patient).  
NA Via a free-phone landline 
to a central server, at 
02h00 daily. Transmission 
failures were followed by a 
call or a message on the 
screen after 7 days (2010a) 
or 24h (2010b). 
Healthcare professionals 
monitored the data. 
Detection of health deterioration 
triggered an automatic email 
message to healthcare professionals, 
who called the patient (on 
weekdays). 
Paré (2006)[34] In the initial home visit, 
provided by a nurse. 
Alerts and advice when 
readings fell outside pre-
set values. 
Over the internet. A nurse monitored the 
data on a daily basis. 
Data outside pre-set values triggered 
an automatic alert to patients and 
the nurse, who contacted the patient 
or the physician for decision-making.  
Sicotte (2011)[38] NA Alerts and advice when 
readings fell outside pre-
defined values. 
Over the internet, in real 
time. 
NA Data outside pre-set values triggered 
automatic alerts to a surveillance 
center and a nurse called the patient. 
Sund (2009)[37] In the initial home visit, 
with an information sheet 
and return demonstration. 
Prompts to attach the 
spirometer to the main 
device. 
To research center, in real 
time. Transmission failures 
for 2 days were followed 
Data monitored by the 
research team, based on 
daily time-score plots 
Exacerbations automatically detected 
by a red line on the time-plots.  
Patients were called to start 
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A helpline was available. by a call. about symptoms and FEV1. treatment with pre-provided 
medications. 
Trappenburg 
(2008)[36] 
NA Each answer received 
immediate feedback from 
the device: praise or 
encouragement to try 
again. 
Via a telephone line to 
Health Hero’s data center. 
Respiratory nurses 
monitored the data on 
weekdays.  
Data automatically stratified and 
color-coded. Nurses received alerts 
and contacted the patient and/or 
notified a pulmonary physician (if 
needed). 
Ure (2012)[35] NA NA Via a secure broadband 
link to a call center. 
Transmission failures were 
followed by a call. 
Staff monitored the data. Staff contacted the patient or 
physician on weekdays according to 
an algorithm. Patients received an 
action plan and emergency supply of 
medication to commence as soon as 
an exacerbation was recognized. 
Physicians provided clinical care at 
weekends. 
NA – no available information; FEV1 – Forced expiratory volume in 1 second.  
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Table 3 – Type and frequency of data collection. 
First author (year) Symptoms Oxygen 
saturation 
Spirometry Heart rate Temperatu
re 
Weight Blood 
pressure 
Respiratory 
rate 
Medication Other 
reports* 
Frequency 
Antoniades 
(2012)[32] 
● ● ●  ● ● ●  ●  Daily, at the same 
time 
Chau (2012)[31]  ●  ●    ●   3X/day on 
weekdays 
Dale (2003)[39]  ●  ●  ●     Daily 
Dinesen (2012)[27], 
Haesum (2012)[28], 
Jensen (2012a)[29], 
Jensen (2012b)[30] 
● ● ● ●  ● ●    According to 
prescription 
Kim (2012a) [23], 
(2012b) [24] 
● ●  ●       Daily 
Koff (2009)[33] ● ● ●      ● ● Daily morning on 
weekdays 
Lewis (2010a)[25], ● ●  ● ●    ●  2X/day, at a  
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(2010b)[26] specific period 
Paré (2006)[34] ●  ●      ●  Daily 
Sicotte (2011)[38] NA NA NA NA NA NA NA NA NA NA Daily 
Sund (2009)[37] ●  ●      ● ● Daily evening 
Trappenburg 
(2008)[36] 
●        ● ● Daily 
Ure (2012)[35] ● ● ●  ●      Daily 
NA – no available information. *Other reports: lung and heart sounds [24], electrocardiogram data [32], number of steps in the 6-minute walking test [33] and questions 
regarding patients’ knowledge about COPD [33, 36]. 
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Table 4 – Patients’ satisfaction with the telemonitoring system. 
First author (year) Measures of patients’ satisfaction Results of patients’ satisfaction 
Antoniades (2012)[32] Non-validated questionnaire related to: ease of use 
of the system; adequacy of technical support; 
system usefulness for disease management; overall 
satisfaction. 
- Easy-to-use system (94%);  
- Good technical support (100%); 
- Useful to manage the disease (82%);  
- Overall satisfaction (88%). 
Chau (2012)[31] Quantitative data: Self-developed satisfaction 
questionnaire (1-5 Lickert scale, 5 being the highest 
level of satisfaction) related to: ease of use; level of 
confidence in using the system; acceptability; 
usefulness; satisfaction with nurse support. 
 
 
 
Qualitative data: Open-ended comments. 
 
 
Quantitative data (% or mean±SD): 
- Overall satisfaction (91%); 
- Adequate explanation (86.3%) and understanding (3.50±1.10); 
- Usage difficulties (2.45±0.80); 
- Mediation reminders (60%); 
- Automated healthcare advice (50%) and nurse support (100%) reassuring; 
- Useful to manage the disease (54.5%); 
- Recommend to others (3.14±089). 
Qualitative data: 
- Facilitated timely care and access to professionals to help decide on the best action; 
- Reminders about medication not helpful because patients remembered to take it. 
38 
 
Difficulties found: 
- Action taken when unexpected characters were displayed (n=5); 
- Instability of data transmission; 
- Small display screen, words, push buttons and power supply; 
- Use of the touch screen, due to decreased sensation and fine motor control; 
- Emergency call button too sensitive; 
- Need of help from caregiver to transmit the data; 
- Use of the belt of respiratory rate sensor (dyspnea, cold water in the winter); 
- Short-lived duration batteries with long time needed to charge. 
Suggestions: add a blood pressure monitor. 
Dale (2003)[39] Satisfaction questionnaire approved by the local 
research and medical ethics committee. 
- Easy-to-use equipment; 
- Health condition well managed; 
- Monitoring service reassuring (no quantitative data reported). 
Kim (2012)[24] Quantitative data: Tool developed by the research 
team to measure attitude toward the system (4-
point Lickert scale questions, from “strongly agree” 
to “strongly disagree”): user satisfaction; intention 
Quantitative data: Most patients were “satisfied” or “very satisfied” with the systems. 
“Agree” or “strongly agree” options were higher for the topics: 
- Physical aspect (n=136); 
- Ease to use (n=129); 
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to use in the future; preferred cost. 
  
Qualitative data: Open-ended questionnaire. 
- Treatment improvement (n=140)  and communication with physician (n=139); 
- Recommendation to others (n=128). 
Qualitative data: Difficulties found: 
- Selection of the precise area to apply the device; 
- Incorrectly connection of the device or error of the server; 
- Learning to use the video phone and adjusting the volume; 
- Limited portability of the device. 
Suggestions: Ensure data transmission, give real-time feedback and include blood pressure 
monitors. 
Koff (2009)[33] Questionnaire about satisfaction with individual 
pieces of the equipment (1-10 Lickert scale: 10 being 
the highest level of satisfaction). 
Satisfaction was very high for all equipments (mean scores 9.6 to 8.5), except for the 
pedometer (4.5), which was not accurate for some patients with gait impairments. 
Lewis (2010a)[25] NA Most patients found it “helpful” or “very helpful” (88%); 1 patient “neither agreed nor 
disagreed” that it was useful; 1 patient found it “inconvenient”. 
Paré (2006)[34] Questionnaire about satisfaction completed by 
telephone (4-point Lickert scale: 4 being the highest 
level of satisfaction) and related to: ease of use; 
Results (mean±SD): 
- Easy-to-use web phone (3.47±1.18); 
- Training (3.76±0.75) and vocabulary used (3.65±0.86); 
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technical support; usefulness. - Problems solved within 24h (3.57±1.09); 
- Sense of security (3.35±1.22); 
- Useful for the adoption of new practices to stabilize health condition (3.65±0.86). 
Sicotte (2011)[38] Validated scale of patient satisfaction (5-point 
Lickert scale: 5 being the highest level of 
satisfaction). Validated scale of the benefits of 
telemonitoring (5-point Lickert scale, 1=very little to 
5=very good). 
Overall satisfaction (mean±SD, 4.6±0.8): 
- Information quality (4.6±0.5), usefulness (4.2±1.4), presentation (4.9±0.4) and 
understanding (4.6±0.7); 
- Data confidentiality and security (4.4±1.0); 
- Ease of use (4.8±0.4) and learning (4.4±0.9); 
- Frequency of use (4.9±0.3); 
- Technical performance (4.2±0.8); 
Perceived benefits (mean±SD): 
- Reassurance (4.2±1.2); 
- More quickly detection of health deterioration (3.6±1.3) and action when it occurred 
(4.1±1.3); 
- Medication taken as prescribed (2.5±1.7). 
Ure (2012)[35] Face-to-face interviews about acceptability of the 
system, specifically: installation; training; use; 
Most patients found the system easy to use and useful: 
- Earlier recognition of exacerbations; 
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disease management; benefits about care, health 
management, recognition of symptoms and feelings; 
concerns; confidentiality; communication with 
healthcare professionals; recommended changes. 
- Facilitated access to professional advice; 
- Confidence to respond to health deterioration; 
- Reassurance. 
Difficulties found: 
- Background noise of the computer fan caused problems in smaller living situations; 
- Uncertainty of data transmission. 
NA – No available information; SD – standard deviation. 
 
 
 
